Hybrid metasurface modulates light at low voltages for energy-efficient optics

Metasurfaces are two-dimensional (2D), nanoengineered surfaces that interact strongly with electromagnetic waves and can ...
Medscape

Novel Drug With New Mechanism Promising for Parkinson’s Motor Fluctuations

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Mid-Day

NMIMS to introduce AI-driven personal interviews for MBA admissions

NMIMS to roll out AI-led interviews with sentiment tracking, measuring facial expressions, tone, and confidence of MBA ...

ESMO25: Relacorilant shows sustained efficacy in PARP-exposed resistant ovarian cancer

Most recurrent ovarian cancer cases arise in patients previously treated with PARP inhibitors making these results noteworthy ...

ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors

Partial remissions and complete metabolic responses in PD-1/PD-L1-resistant cancers First-in-class multi-checkpoint inhibitor with robust ...
The Malaysian Reserve

FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis

Orphan Drug Designation granted to CK0803 for Amyotrophic Lateral Sclerosis CK0803 is CNS Homing Tregs expressing CXCR3hi, ...
UroToday

ESMO 2025 Discussion: Insights on PETRANHA (Saruparib + ARPI) and Pasritamig (JNJ-78278343) in Advanced Prostate Cancer

(UroToday.com) The 2025 European Society of Medical Oncology (ESMO) Annual Congress held in Berlin, Germany between September 17 th and 21 st was host to the session Mini oral session: GU tumours, ...

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

NuCana PLC (NASDAQ: NCNA) gained 22.1% to $6.19 in pre-market trading. NuCana highlighted synergy between NUC-7738 and PD-1 inhibitors in RCC Organoids, supporting expansion of NuTide:701 clinical ...